Research Article
Exploring the Mechanism of Panax notoginseng Saponins against Alzheimer’s Disease by Network Pharmacology and Experimental Validation
Table 2
Result of KEGG pathway enrichment analysis.
| Term ID | Pathway name | Count | FDR |
| hsa04080 | Neuroactive ligand-receptor interaction | 48 | 6.66E − 56 | hsa05200 | Pathways in cancer | 45 | 1.02E − 39 | hsa04151 | PI3K-Akt signaling pathway | 30 | 2.71E − 25 | hsa05167 | Kaposi’s sarcoma-associated herpesvirus infection | 25 | 2.71E − 25 | hsa01522 | Endocrine resistance | 21 | 3.65E − 25 | hsa05212 | Pancreatic cancer | 19 | 7.79E − 24 | hsa05205 | Proteoglycans in cancer | 24 | 1.34E − 23 | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 19 | 1.39E − 23 | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 18 | 1.86E − 20 | hsa04012 | ErbB signaling pathway | 16 | 1.63E − 18 | hsa05206 | MicroRNAs in cancer | 18 | 1.27E − 17 | hsa05215 | Prostate cancer | 16 | 1.29E − 17 | hsa04068 | FoxO signaling pathway | 17 | 3.22E − 17 | hsa05210 | Colorectal cancer | 15 | 5.56E − 17 | hsa04917 | Prolactin signaling pathway | 14 | 1.27E − 16 | hsa05203 | Viral carcinogenesis | 18 | 2.49E − 16 | hsa04066 | HIF-1 signaling pathway | 14 | 7.61E − 15 | hsa04024 | cAMP signaling pathway | 17 | 1.00E − 14 | hsa05224 | Breast cancer | 15 | 5.98E − 14 | hsa05214 | Glioma | 12 | 8.70E − 14 | hsa04914 | Progesterone-mediated oocyte maturation | 13 | 1.03E − 13 | hsa05165 | Human papillomavirus infection | 19 | 1.03E − 13 | hsa05218 | Melanoma | 12 | 1.44E − 13 | hsa05231 | Choline metabolism in cancer | 13 | 1.57E − 13 | hsa04659 | Th17 cell differentiation | 13 | 2.42E − 13 | hsa05220 | Chronic myeloid leukemia | 12 | 2.42E − 13 | hsa05418 | Fluid shear stress and atherosclerosis | 14 | 2.56E − 13 | hsa05226 | Gastric cancer | 14 | 7.94E − 13 | hsa04014 | Ras signaling pathway | 16 | 1.06E − 12 | hsa05221 | Acute myeloid leukemia | 11 | 1.34E − 12 |
|
|